Works matching DE "ABDOMINAL cancer"


Results: 198
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10

    Phase I trial of autologous hematopoietic SCT with escalating doses of topotecan combined with CY and carboplatin in patients with relapsed or persistent ovarian or primary peritoneal carcinoma.

    Published in:
    Bone Marrow Transplantation, 2010, v. 45, n. 3, p. 490, doi. 10.1038/bmt.2009.181
    By:
    • Litzow, M. R.;
    • Peethambaram, P. P.;
    • Safgren, S. L.;
    • Keeney, G. L.;
    • Ansell, S. M.;
    • Dispenzieri, A.;
    • Elliott, M. A.;
    • Gastineau, D. A.;
    • Gertz, M. A.;
    • Inwards, D. J.;
    • Lacy, M. Q.;
    • Micallef, I. N. M.;
    • Porrata, L. F.;
    • Lingle, W. L.;
    • Hartmann, L. C.;
    • Frost, M. H.;
    • Barrette, B. A.;
    • Long, H. J.;
    • Suman, V. J.;
    • Reid, J. M.
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21

    Interpleural block – part 2.

    Published in:
    Anaesthesia, 2007, v. 62, n. 11, p. 1143, doi. 10.1111/j.1365-2044.2007.05181.x
    By:
    • Dravid, R. M.;
    • Paul, R. E.
    Publication type:
    Article
    22
    23

    Radiotherapy of abdomen with precise renal assessment with SPECT/CT imaging (RAPRASI): design and methodology of a prospective trial to improve the understanding of kidney radiation dose response.

    Published in:
    BMC Cancer, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2407-13-381
    By:
    • Lopez-Gaitan, Juanita;
    • Ebert, Martin A.;
    • Robins, Peter;
    • Boucek, Jan;
    • Leong, Trevor;
    • Willis, David;
    • Bydder, Sean;
    • Podias, Peter;
    • Waters, Gemma;
    • O'Mara, Brenton;
    • Chu, Julie;
    • Faggian, Jessica;
    • Williams, Luke;
    • Hofman, Michael S.;
    • Spry, Nigel A.
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36

    A randomized phase II multicenter trial to explore efficacy of weekly intraperitoneal in comparison with intravenous paclitaxel administered immediately after gastrectomy to the patients with high risk of peritoneal recurrence: final results of the INPACT trial.

    Published in:
    Gastric Cancer, 2018, v. 21, n. 6, p. 1014, doi. 10.1007/s10120-018-0817-y
    By:
    • Takahashi, Naoto;
    • Kanda, Mitsuro;
    • Yoshikawa, Takaki;
    • Takiguchi, Nobuhiro;
    • Fujitani, Kazumasa;
    • Miyamoto, Katsufumi;
    • Ito, Yuichi;
    • Takayama, Osamu;
    • Imano, Motohiro;
    • Mitsumori, Norio;
    • Sakamoto, Junichi;
    • Morita, Satoshi;
    • Kodera, Yasuhiro
    Publication type:
    Article
    37

    Ramucirumab for the treatment of metastatic gastric or gastroesophageal junction adenocarcinoma following disease progression on first-line platinum- or fluoropyrimidine-containing combination therapy in Japanese patients: a phase 2, open-label study.

    Published in:
    Gastric Cancer, 2018, v. 21, n. 6, p. 1041, doi. 10.1007/s10120-018-0811-4
    By:
    • Yamaguchi, Kensei;
    • Fujitani, Kazumasa;
    • Nagashima, Fumio;
    • Omuro, Yasushi;
    • Machida, Nozomu;
    • Nishina, Tomohiro;
    • Koue, Toshiko;
    • Tsujimoto, Mika;
    • Maeda, Kaijiro;
    • Satoh, Taroh
    Publication type:
    Article
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50